Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
certepetide
DRUG
2 trials
Sponsors
Lisata Therapeutics, Inc.
Conditions
Bile Duct Cancer
Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Gall Bladder Cancer
Gall Bladder Carcinoma
Gallbladder Cancer
Gallbladder Carcinoma
Intrahepatic Cholangiocarcinoma
+8 more
Phase 1
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
Withdrawn
NCT06592664
Lisata Therapeutics, Inc.
Metastatic Pancreatic Cancer, Pancreas Adenocarcinoma, Pancreas Cancer +5
Start: 2030-01-31
End: 2040-01-31
Updated: 2025-06-06
Phase 2
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Terminated
NCT05712356
Lisata Therapeutics, Inc.
Bile Duct Cancer, Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma +5
Start: 2023-05-13
End: 2026-04-05
Updated: 2026-05-26